Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

0.9001
Delayed Data
As of 11:31am ET
 +0.0027 / +0.30%
Today’s Change
0.81
Today|||52-Week Range
9.72
-82.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 2
2017
Revenue and IncomeNet Revenues2.4M2.2M2.0M870.0K
 
 
 
 
 
Cost of Goods Sold2.0M1.8M2.0M569.0K
 
 
 
 
 
 
Operating ExpensesGross Income423.0K410.0K17.0K301.0K
 
 
 
 
 
General Expenses3.8M4.4M4.3M1.7M
 
 
 
 
 
Research And Development618.0K879.0K818.0K476.0K
 
 
 
 
 
Total Operating Expenses5.8M6.1M6.3M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-3.9M-4.3M-1.4M
 
 
 
 
 
Interest Expense On Debt--16.0K563.0K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-4.0M-4.9M-1.1M
 
 
 
 
 
Income Taxes-6.0K-10.0K-56.0K0.00
 
 
 
 
Discontinued Operations0.000.000.00-929.0K
 
 
Net Income-3.4M-4.0M-4.8M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M1.7M1.8M2.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.7M1.7M1.8M2.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.92-$2.28---$0.81
 
 
 
 
EPS Diluted-$1.92-$2.28-$2.76-$0.81